U.S. Capital Advisors »

GlaxoSmithKline shares owned by U.S. Capital Advisors

Quarter-by-quarter ownership of GlaxoSmithKline shares owned by U.S. Capital Advisors from 13F filings

Historical chart of U.S. Capital Advisors investment in GlaxoSmithKline

Tip: Access up to 7 years of quarterly data

All positions including GlaxoSmithKline held by U.S. Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in GlaxoSmithKline by U.S. Capital Advisors

Quarter filed Position value Share count Share price at filing
2013-03-31 $85k 1.8k 47.01
2012-09-30 $88k 1.9k 46.29
2011-12-31 $19k 418 45.45

More positions owned by U.S. Capital Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
Enterprise Products Partners (EPD)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Total Stk Mkt (VTI)
Cisco Systems (CSCO)
JPMorgan Chase & Co. (JPM)
Pfizer (PFE)
Abbvie (ABBV)
Ark Etf Tr Innovation Etf (ARKK)
Johnson & Johnson (JNJ)
Chevron Corporation (CVX)

View all positions for U.S. Capital Advisors

Top funds holding GlaxoSmithKline

Kahn Brothers Group
Damian Sousa
Columbia Asset Management
Paradigm Asset Management Company
Accent Capital Management
Park Circle
Byrne Asset Management
Retirement Group
Huntington National Bank

View all funds holding GlaxoSmithKline